Introduction {#sec1_1}
============

Early recognition and intervention of cognitive impairment and dementia are considered as desirable. Early diagnosis allows people with dementia to facilitate planning while they still have the cognitive capacity to make important decisions about their future care. They can obtain access to available drug and non-drug therapies only after receiving a diagnosis, which may improve their cognition and enhance their quality of life \[[@B1]\].

Regarding early diagnosis of dementia, depression is important as it is associated with cognitive decline, represents a risk factor for dementia, and is distinguished from cognitive decline. Depression masquerading as dementia is likely the most common differential diagnosis and should always be considered; however, they can coexist, and depression may precede dementia \[[@B2]\]. Late-onset depression can be associated with the development of dementia \[[@B3]\]. It is unclear whether late-onset depression is a risk factor for or an early symptom of dementia \[[@B4]\]. In addition, a recent report indicated that mild cognitive impairment is a risk factor for depression \[[@B5]\].

Older adults with memory complaints who seek medical help are more likely to have close relatives with dementia. They also consider their complaints as serious concerns with underlying biomedical reasons and do not hold negative views about their doctor \[[@B6], [@B7]\]. This population includes people who will develop dementia in the future and "worried well" individuals who are more concerned but perform normally in memory and non-memory tests \[[@B8]\]. Additional insight into whether older adults with memory complaints seek medical help is important for population-based interventions likely to be successful in decreasing cognitive severity at diagnosis of dementia. Thus, a comprehensive overview of this population is useful for not only clinical interventions but also strategies to increase early diagnosis of dementia. This population presents a high level of depressive symptomatology compared to the healthy population \[[@B9]\].

Brain imaging has started to yield information about the existence of biological bases of depression. Patients with major depression were characterized by diffuse bilateral grey matter loss in ventrolateral and ventromedial frontal systems extending into temporal gyri compared to healthy controls \[[@B10]\]. Another study demonstrated reduced right lateral inferior fontal volumes in major depression disorder \[[@B11]\]. Associations between depression and brain morphology of older adults with memory complaints who seek medical help have not been well documented.

This study focused on individuals who visited a memory clinic unaccompanied (UA), obviously included in older adults with memory complaints who seek medical help. We hypothesized that a relatively high level of depressive symptoms is a characteristic of UA individuals, associated with the brain structure. To test this hypothesis, we compared the degree of depressive symptoms of UA individuals with that of accompanied (AC) individuals, and we further investigated the relationship between the degree of depressive symptoms and brain structure for each group.

Materials and Methods {#sec1_2}
=====================

Participants {#sec2_1}
------------

Participants were consecutive outpatients aged \> 65 years who visited the Nozomi Memory Clinic, an open-access institution, for the first time between September 2015 and February 2016. We retrospectively investigated 21 UA subjects and 75 AC subjects who had obtained neuroimaging data. This study was approved by the Asai Dermatology Institutional Review Board. Using the public website and in-hospital posters, we disclosed the prescribed information and gave the subjects or, where appropriate, their nearest relatives the possibility to refuse participation.

Neuropsychological Tests {#sec2_2}
------------------------

Neuropsychological tests involved the Mini-Mental State Examination (MMSE) and the Center for Epidemiologic Studies Depression Scale (CES-D) for evaluation of depressive symptoms.

Image Acquisition and Analysis {#sec2_3}
------------------------------

The subjects underwent brain magnetic resonance imaging (MRI) scans using a 1.5-tesla Optima MR360 Advance (General Electric Healthcare, Milwaukee, WI, USA), with an 8-channel head coil. High-resolution T1-weighted images were acquired with a three-dimensional fast spoiled gradient-recalled echo (TR = 10.7 ms, echo time = 4.3 ms, flip angle = 15°, voxel size = 1.0 × 1.0 × 1.0 mm^3^ and matrix size = 256 × 256), yielding 120--150 contiguous slices of 1.2-mm thickness in the sagittal plane, which were used for surface-based analysis. For participants with a neuropsychological assessment, all scans were performed within 1 month from cognitive testing. We identified the volumes of regions of interest (ROI volumes) using FreeSurfer software (version 5.3, [http://surfer.nmr.mgh.harvard.edu/](http://www.surfer.nmr.mgh.harvard.edu/)). This processing includes motion correction, removal of non-brain tissue using a hybrid watershed/surface deformation procedure, automated Talairach transformation, segmentation of the subcortical white matter and deep gray matter volumetric structures, intensity normalization, tessellation of the gray matter white matter boundary, automated topology correction, and surface deformation following intensity gradients to optimally segment borders at the location where the greatest shift in intensity defines the transition to the other tissue class \[[@B12]\]. The ROI included six limbic system and subcortical structures (hippocampus, amygdala, thalamus, caudate nucleus, putamen, and globus pallidus) and 31 cortical regions based on the Desikan-Killiany-Tourville atlas \[[@B13]\]. Our clinic analyzes head MRIs using FreeSurfer software in routine practice, and additional analysis by FreeSurfer has not been done for this research. The reconstructed images were visually examined without knowledge of the subjects\' identities. From 27 subjects in the UA group and 101 subjects in AC group who obtained scanned data, 6 subjects of the UA group and 26 subjects of the AC group were excluded because of segmentation errors. For normalization, each subject\'s ROI volumes were divided by the volume of their entire brain.

Statistical Analysis {#sec2_4}
--------------------

We compared basic demographic characteristics between UA and AC individuals using a *t* test or χ^2^ test as appropriate. Comparisons of MMSE and CES-D scores between the groups were examined using an analysis of covariance (ANCOVA). Within each groups, we further examined the correlation between the normalized ROI volumes and the CES-D scores. Multiple comparisons using the Bonferroni correction were done for each hemisphere.

Results {#sec1_3}
=======

This study included 21 UA subjects and 75 AC subjects. Regarding the gender ratio, subject groups were similar (χ^2^ = 1.329, *p* = 0.2490) (Table [1](#T1){ref-type="table"}). Subjects in the UA group had significantly lower ages (*p* \< 0.001), higher MMSE scores (*p* \< 0.001, ANCOVA controlling for age and sex), and higher CES-D scores (*p* = 0.0054, ANCOVA controlling for age, sex, and MMSE score) than those in the AC group.

ROI volumes of 21 UA subjects and 75 AC subjects were identified. In UA subjects, volumes of the right superior temporal gyrus (STG) were strongly associated with CES-D scores (*r* = −0.7234, *p* = 0.0002, remaining significant after Bonferroni correction) (Table [2](#T2){ref-type="table"}). Volumes of left STG were only moderately associated with CES-D scores (*r* = −0.6127, *p* = 0.0032, not significant after Bonferroni correction). Both associations were negative. No significant correlation was found between CES-D scores and normalized ROI volumes in AC subjects (data not shown).

Discussion {#sec1_4}
==========

This study demonstrated that subjects in the UA group had higher CES-D scores than those in the AC group, and CES-D scores of UA subjects were inversely associated with the normalized volume of the right STG and only moderately associated with the left STG. There was no association between CES-D scores and normalized ROI volumes in AC subjects; this may have been due to clinical heterogeneity of AC subjects.

We focused on UA subjects as they chose our clinic to get their symptoms treated, made a reservation, and visited the clinic as scheduled. Hence, they had well-maintained executive functions and sought medical help on their own accord. Since our clinic\'s name contains "Memory," we are known as specializing in problems related to memory. Typically, individuals who visit our clinic on their own accord are self-aware of their memory impairment. Thus, UA subjects were included in our analysis of older adults with memory complaints seeking medical help.

The right STG is activated during theory of mind tasks \[[@B14]\]. This area is associated with attention to emotion \[[@B15]\] and face processing \[[@B16]\]. Decreased volume of the right STG is considered as a structural neural marker of social-emotional information evaluation abnormalities \[[@B17]\]. A volumetric study demonstrated reduction in the volume of the left STG in patients with anxiety disorders \[[@B11]\]. In addition, the CES-D scale evaluates both depression and anxiety \[[@B18], [@B19]\]. Together with these findings, our results indicate that a relatively high level of depressive symptoms in UA subjects was caused by problems of emotion processing especially anxiety, considering the inverse association with STG volume. This may correspond to the findings that older adults with memory complaints seeking medical help are more likely to have a relatively high level of concern \[[@B7]\].

Our results also suggest that depressive symptoms of UA subjects demonstrated by the relatively high levels of CES-D scores were primary, because of the inverse association with the normalized volume of bilateral STG. Thus, focusing on the depressive symptoms may be a suitable approach to satisfy potential medical needs of UA subjects with or without memory impairment. This may be supported by the findings that mild cognitive impairment is a risk factor for depression \[[@B5]\].

Importantly, the demographics of UA subjects vary owing to new medical developments and enlightenments on cognitive impairment. Sample size limitation, potential clinical heterogeneity of subjects, and a retrospective cross-sectional design of this study precluded definitive conclusions and did not allow for the generalization. Whether the negative correlation between CES-D scores and normalized volumes of STG in UA subjects was due to a disease remains unclear. Although our findings have limitations, the results indicated that memory clinics may play a role as the entrance to medical care both for people with depression as well as for people with dementia or at risk of dementia. Additional prospective studies are needed to confirm our findings.
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###### 

Participant characteristics

                 Unaccompanied   Accompanied   *p* value
  -------------- --------------- ------------- -------------------------------------------------------
  Age, years     76.1 (5.2)      81.2 (6.4)    \<0.001[^a^](#T1F1){ref-type="table-fn"}
  Females, *n*   12 (57%)        50 (67%)      χ^2^ = 1.329, 0.2490[^b^](#T1F2){ref-type="table-fn"}
  MMSE score     26.6 (2.7)      19.6 (6.4)    \<0.001[^c^](#T1F3){ref-type="table-fn"}
  CES-D score    13.4 (10.6)     8.9 (6.1)     0.0054[^d^](#T1F4){ref-type="table-fn"}

Data are presented as mean (SD) or as stated. Characteristics were measured during the subjects\' first visit to the clinic. MMSE, Mini-Mental State Examination; CES-D, Center for Epidemiologic Studies Depression Scale.

Student *t* test.

χ^2^ (df = 1).

Analysis of covariance (df = 1) controlling for age and sex.

Analysis of covariance (df = 1) controlling for age, sex, and MMSE score.

###### 

Correlations between CES-D scores and normalized ROI volumes in 21 subjects who visited the memory clinic unaccompanied

                                                              Correlation coefficient (p value)                   
  ----------------------------- ----------------------------- --------------------------------------------------- -----------------------------------------------------------------------------------
  Temporal lobe                 Entorhinal                    −0.1259 (0.5867)                                    −0.2260 (0.3247)
                                Parahippocampal               −0.2572 (0.2604)                                    −0.05378 (0.8169)
                                Fusiform                      −0.2772 (0.2238)                                    −0.1985 (0.3883)
                                Superior temporal             −0.6127 (0.0032) [\*](#T2F1){ref-type="table-fn"}   −0.7234 (0.0002)[\*](#T2F1){ref-type="table-fn"}[^a^](#T2F2){ref-type="table-fn"}
                                Middle temporal               0.1872 (0.4166)                                     −0.4574 (0.0371)
                                Inferior temporal             −0.4080 (0.0663)                                    −0.1398 (0.5455)
                                Transverse temporal           −0.2081 (0.3653)                                    −0.1511 (0.5133)
                                                                                                                  
  Frontal lobe                  Superior frontal              −0.01974 (0.9323)                                   0.2542 (0.2662)
                                Rostral middle frontal        −0.04575 (0.8439)                                   −0.1818 (0.4303)
                                Caudal middle frontal         0.005405 (0.9814)                                   −0.1057 (0.6485)
                                Pars opercularis              −0.06774 (0.7705)                                   −0.1861 (0.4192)
                                Pars triangularis             −0.1007 (0.6641)                                    0.1325 (0.5472)
                                Pars orbitalis                0.07966 (0.7314)                                    −0.2382 (0.2985)
                                Lateral orbitofrontal         −0.3165 (0.1622)                                    −0.3312 (0.1425)
                                Medial orbitofrontal          −0.4063 (0.0676)                                    −0.1054 (0.6493)
                                Precentral                    −0.2992 (0.1877)                                    −0.1713 (0.4578)
                                Paracentral                   −0.07685 (0.7406)                                   −0.05988 (0.7965)
                                                                                                                  
  Parietal lobe                 Postcentral                   0.1746 (0.4491)                                     0.04223 (0.8558)
                                Supramarginal                 −0.3844 (0.0853)                                    −0.4493 (0.0410)
                                Superior parietal             −0.5369 (0.0121)                                    −0.1594 (0.4901)
                                Inferior parietal             0.2238 (0.3294)                                     −0.1172 (0.6129)
                                Precuneus                     −0.04942 (0.8315)                                   −0.2067 (0.3686)
                                                                                                                  
  Occipital lobe                Lingual                       −0.1801 (0.4347)                                    −0.1524 (0.5096)
                                Pericalcarine                 −0.1028 (0.6574)                                    −0.1175 (0.6121)
                                Cuneus                        −0.02497 (0.9145)                                   0.04744 (0.8382)
                                Lateral occipital             0.1883 (0.4138)                                     −0.07079 (0.7604)
                                                                                                                  
  Cingulate cortex and insula   Rostral anterior cingulated   −0.3389 (0.1329)                                    −0.1245 (0.5893)
                                Caudal anterior cingulate     0.1381 (0.5505)                                     −0.1937 (0.4001)
                                Posterior cingulate           0.1440 (0.5333)                                     0.2519 (0.2706)
                                Isthmus cingulate             −0.2522 (0.2700)                                    −0.1213 (0.6005)
                                Insula                        −0.1655 (0.4374)                                    −0.1355 (0.5580)
                                                                                                                  
  Limbic system and thalamus    Hippocampus                   0.1819 (0.4300)                                     −0.03129 (0.8929)
                                Amygdala                      0.1763 (0.4447)                                     −0.2156 (0.3480)
                                Thalamus                      −0.1780 (0.4401)                                    −0.18875 (0.4126)
                                                                                                                  
  Basal ganglia                 Putamen                       0.1375 (0.5522)                                     −0.1489 (0.5194)
                                Caudate nucleus               0.1088 (0.6385)                                     0.1023 (0.6569)
                                Globus pallidus               −0.05053 (0.8278)                                   −0.07744 (0.7387)

*p* \> 0.01.

Significant after Bonferroni correction.
